The Australian Government is introducing free Respiratory Syncytial Virus (RSV) vaccinations for older Australians to ensure they are protected from the this common and potentially life threatening respiratory virus.

The government has committed $445.3 million to fund access to the vaccine Arexvy, which would otherwise cost around $300 per dose.

From 15 May, Australians aged 75 and over, and Aboriginal and Torres Strait Islander people aged 60 and over, will be eligible for a free RSV vaccine through the National Immunisation Program (NIP). Eligible people will be able to receive the vaccine through GPs, immunisation clinics, community and Aboriginal health services and participating pharmacies.

RSV is a common respiratory virus that can lead to hospitalisation, intensive care and death. Aged care residents are particularly vulnerable due to shared living arrangements and frequent contact with staff and visitors.

The addition of the RSV vaccine on the NIP for older adults complements the free NIP influenza and COVID-19 vaccine programs.